BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BridgeBio Pharma approved inducement grants of 57,853 restricted stock units to 32 new employees on October 14, 2026. The awards were granted under Nasdaq Listing Rule 5635(c)(4) outside the shareholder-approved equity plan process, with a four-year vesting schedule beginning November 16, 2027.
Key figures
- New employees
- 32
- Inducement rsus
- 57853
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.